Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1561–1584 of 1,640 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Sexual Activity Clear all

Conditions: Vaginismus, Dyspareunia
Interventions: Milli Vaginal Dilator; Device
Lead sponsor: Materna Medical; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Mountain View, California

Conditions: Sex, Unsafe, Drug Use
Interventions: Communication skills training video, substance use module, Couples HIV Testing and Counseling; Behavioral
Lead sponsor: Hunter College of City University of New York; Other
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Child Sexual Abuse
Interventions: group therapy, Treatment as usual; Behavioral · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older · Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Prostate Cancer, Male Erectile Disorder, Stage I Prostate Cancer, Stage II Prostate Cancer
Interventions: sildenafil citrate, alprostadil, robotic-assisted laparoscopic surgery, quality-of-life assessment, questionnaire administration; Drug · Procedure · Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Duarte, California

Conditions: Vulvodynia, Dyspareunia, Breast Cancer, Menopause
Interventions: Topical liquid lidocaine, Topical saline; Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Nerve Injury, Prostate Cancer
Interventions: 4-Aminopyridine, Placebo; Drug · Other
Lead sponsor: John Elfar; Other
Eligibility: 45 Years to 75 Years · Male only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 2
States / cities: Tucson, Arizona • Rochester, New York

Conditions: HIV Infections
Interventions: somatropin, Hepatitis A virus, inactivated, Keyhole-Limpet Hemocyanin; Drug · Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2005
U.S. locations: 13
States / cities: Birmingham, Alabama • Los Angeles, California • Sacramento, California + 7 more

Conditions: HIV Infections
Interventions: Adefovir dipivoxil; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • New York, New York + 2 more

Conditions: Gender Identity Disorder of Adult, Voiding Disorders, Sexual Dysfunction
Interventions: Focus group interviews, Questionnaire packet; Other · Diagnostic Test
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Erectile Dysfunction
Interventions: Tadalafil, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 623 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 34
States / cities: Huntsville, Alabama • Lancaster, California • Newport Beach, California + 31 more

Conditions: Alcohol Use, Unspecified, Substance Use, Sex Behavior
Interventions: PrEP acronym (pre-exposure prophylaxis), Initial Web Survey, Interactive Voice Response (IVR) monitoring, Educational material on alcohol and sexual health behavior, Interactive Voice Response (IVR) assessment with personalized information, Personalized information based on web-based survey responses & standardized information; Drug · Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 30 Years · Male only
Enrollment: 88 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: HIV -1 Infection, HIV (Human Immunodeficiency Virus), HIV, HIV 1 Infection
Interventions: Bictegravir, emtricitabine, and tenofovir alafenamide; Drug
Lead sponsor: CAN Community Health; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 10
States / cities: Clearwater, Florida • Ft. Pierce, Florida • Jacksonville, Florida + 6 more

Conditions: Cancer Survivor, Depression, Gastrointestinal Complications, Male Erectile Disorder, Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment, Urinary Complications
Interventions: telephone-based intervention, educational intervention, partner-assisted coping skills training, questionnaire administration, psychosocial assessment and care, quality-of-life assessment; Behavioral · Other · Procedure
Lead sponsor: East Carolina University; Other
Eligibility: Not listed
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: HIV Infections
Interventions: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg, Placebo Oral Tablet; Drug
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years to 39 Years
Enrollment: 1,219 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Sexual Health
Interventions: Ashwagandha, Placebo; Dietary Supplement · Other
Lead sponsor: SF Research Institute, Inc.; Network
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Infection, Human Immunodeficiency Virus I
Interventions: LEXIVA (GW433908), Ritonavir; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 2 Years to 18 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2013
U.S. locations: 16
States / cities: Birmingham, Alabama • Los Angeles, California • Oakland, California + 10 more

Conditions: Heavy Drinking, Mental Health Issue
Interventions: LGBTQ-affirmative Cognitive Behavioral Therapy, LGBTQ-affirmative Treatment-As-Usual; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 274 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Depression, Anxiety, Suicide, Drug Use
Interventions: eHealth Familias Unidas Mental Health; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 12 Years to 16 Years
Enrollment: 468 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 17
States / cities: Miami, Florida

Conditions: Female Sexual Dysfunction
Interventions: arginine 20%, nicotinamide .01%, niacin.1%, in LipodermPG 50%, Topical study cream, GRAS cream; Drug
Lead sponsor: East Suburban Ob Gyn; Other
Eligibility: 25 Years to 60 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Monroeville, Pennsylvania

Conditions: HIV
Interventions: Exercise, Stretching and Social Interaction; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 40 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: HIV Infections
Interventions: VRC01, VRC01LS; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 3
States / cities: Cleveland, Ohio • Philadelphia, Pennsylvania • Seattle, Washington

Conditions: Erection; Incomplete
Interventions: Pornography Abstinence; Behavioral
Lead sponsor: Efforia, Inc; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Dating Violence, Alcohol Drinking
Interventions: Promoting Resilient Youth with Strong Hearts and Minds (PRYSHM); Behavioral
Lead sponsor: University of Nebraska Lincoln; Other
Eligibility: 15 Years to 18 Years
Enrollment: 314 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Hypoactive Sexual Desire Disorder
Interventions: Placebo vulvar cream, Estradiol vulvar cream; Other
Lead sponsor: ProHealth Care, Inc; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Waukesha, Wisconsin

Search by objective public record fields.

Prospective on Market Patient-reported Outcomes for Milli

Addressing Substance Use Through CVCT

Tertiary Prevention of Child Sexual Abuse

ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer

Therapy to Prevent Sexual Pain in Breast Cancer Survivors

4-aminopyridine Treatment for Nerve Injury

Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs

A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs

Transgender Post-reassignment Urogynecologic Measures and Perceptions

A Study in Erectile Dysfunction

ANCHORS Alcohol & Sexual Health Study: UH3 Project

REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE

Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer

Botswana TDF/FTC Oral HIV Prophylaxis Trial

Effects of Ashwagandha Extract (Capsule KSM-66 300 mg) on Sexual Health in Healthy Women

48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health

Mental Health in Primary Care

Assessing the Effects of a Topically Applied Cream to Clitoral Blood Flow

Exercise Training to Improve Brain Health in Older HIV+ Individuals

Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults

Pornography Abstinence and Nocturnal Erections in Adult Men

Evaluation of PRYSHM for LGBTQIA2S+ Youth

A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women